Mary L. Morris
- Immunology top 5%
- Epidemiology top 10%
- Molecular Biology
- Infectious Diseases top 10%
- Hepatology top 10%
- Co-authors
- Heather L. DavisCurtis CooperD. William CameronSusan M. EflerA M KriegJenny HeathcoteIsabelle SeguinJohn B. Stanbury
- Topics
- Immune Response and Inflammation (4 papers)Hepatitis B Virus Studies (4 papers)Immunotherapy and Immune Responses (3 papers)
- Cited by
- ImmunologyVirologyHepatology
- Journals
- Journal of Biological ChemistryThe Journal of Clinical Endocrinology & MetabolismEndocrinology
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Mary L. Morris
15 papers receiving 790 citations
Peers
Comparison fields: 5 of 85
- Immunology 515
- Epidemiology 308
- Molecular Biology 227
- Infectious Diseases 124
- Hepatology 97
Countries citing papers authored by Mary L. Morris
This map shows the geographic impact of Mary L. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary L. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary L. Morris more than expected).
Fields of papers citing papers by Mary L. Morris
This network shows the impact of papers produced by Mary L. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary L. Morris. The network helps show where Mary L. Morris may publish in the future.
Co-authorship network of co-authors of Mary L. Morris
This figure shows the co-authorship network connecting the top 25 collaborators of Mary L. Morris. A scholar is included among the top collaborators of Mary L. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary L. Morris. Mary L. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 7 | |
| 3 | 162 | |
| 4 | 270 | |
| 5 | 91 | |
| 6 | 209 | |
| 7 | 1 | |
| 8 | CpG ODN is safe and highly effective in humans as adjuvant to HBV vaccine Preliminary results of phase I trial with CpG ODN 7909 | 14 |
| 9 | 2 | |
| 10 | 6 | |
| 11 | 3 | |
| 12 | The quantitation of the Renografin-iodine-131 renogram for renal clearance determination. | 3 |
| 13 | 16 | |
| 14 | 50 | |
| 15 | 13 |
About Mary L. Morris
Mary L. Morris is a scholar working on Hepatology, Virology and Immunology, having authored 15 papers that have together received 860 indexed citations. Recurring topics across this work include Immune Response and Inflammation (4 papers), Hepatitis B Virus Studies (4 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Immunology (515 citations), Virology (77 citations) and Hepatology (97 citations). Mary L. Morris has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Heather L. Davis, Curtis Cooper, D. William Cameron, Susan M. Efler, A M Krieg, Jenny Heathcote, Isabelle Seguin, John B. Stanbury, Arthur Μ. Krieg and Jonathan B. Angel. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.